Cardiac Imaging Clinical Trial
Official title:
Respiratory Motion Correction of Cardiac Combined Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI)
NCT number | NCT03200132 |
Other study ID # | 16-4-156 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 26, 2017 |
Est. completion date | October 14, 2021 |
Verified date | April 2022 |
Source | Maastricht University Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study evaluates the possibility of Magnetic Resonance Imaging (MRI) based respiratory motion correction of simultaneously acquired cardiac Positron Emission Tomography (PET) images.
Status | Completed |
Enrollment | 15 |
Est. completion date | October 14, 2021 |
Est. primary completion date | October 14, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - 18F-FDG injection for clinical diagnostic PET/MRI or PET/CT Exclusion Criteria: - Diet-suppressed myocardial uptake of 18F-FDG - General exclusion criteria for MRI (i.e. metallic implants, claustrophobia, pregnancy, etc.) - Not willing to be informed about incidental findings |
Country | Name | City | State |
---|---|---|---|
Netherlands | Maastricht University Hospital | Maastricht | Limburg |
Lead Sponsor | Collaborator |
---|---|
Maastricht University Medical Center |
Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Target-to-background ratio (TBR) | 15-20 minutes | ||
Secondary | Signal-to-noise ratio (SNR) | 15-20 minutes |